Quarterly Insider Transactions at Revance Therapeutics, Inc. (RVNC)
Shares Bought
Shares Sold
RVNC Insider transactions
| Quarter | Buy / Adquisition | Sell / Disposition | Net Activity | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Traded Shares | Avg. Price /p share | Transactions | Insiders | Traded Shares | Avg. Price /p share | Transactions | Insiders | |||
| Q2 2024 | 107K | $0.48 $51,835 | 9 | 9 | 2.39K | $3.8 $9,089 | 1 | 1 | 105K | |
| Q1 2024 | 342K | $1.0 $341,139 | 7 | 4 | 57.3K | $5.2 $298,040 | 8 | 4 | 285K | |
| Q4 2023 | 962 | $7.47 $7,186 | 3 | 3 | 4.71K | $8.08 $38,072 | 1 | 1 | (3.75K) | |
| Q3 2023 | 187K | $0.0 $0 | 4 | 4 | 167K | $20.34 $3.39 Million | 9 | 4 | 19.8K | |
| Q2 2023 | 27.1K | $5.9 $159,788 | 11 | 10 | 183K | $32.13 $5.87 Million | 11 | 5 | (156K) | |
| Q1 2023 | 5.2K | $0.0 $0 | 1 | 1 | 164K | $31.09 $5.11 Million | 16 | 4 | (159K) | |
| Q4 2022 | 1.86K | $12.18 $22,593 | 3 | 3 | 53.7K | $23.32 $1.25 Million | 3 | 3 | (51.9K) | |
| Q3 2022 | 313K | $0.0 $0 | 4 | 4 | 11K | $27.07 $297,770 | 1 | 1 | 302K | |
| Q2 2022 | 45.4K | $3.53 $159,957 | 10 | 10 | — | 45.4K | ||||
| Q1 2022 | 313K | $0.0 $0 | 4 | 4 | 27.2K | $14.66 $399,457 | 13 | 6 | 286K | |
| Q4 2021 | 113K | $11.39 $1.28 Million | 5 | 5 | 44.2K | $18.31 $808,513 | 3 | 3 | 68.6K | |
| Q3 2021 | — | 126K | $28.71 $3.61 Million | 6 | 2 | (126K) | ||||
| Q2 2021 | 23.6K | $7.23 $170,723 | 10 | 10 | 413 | $28.22 $11,654 | 2 | 2 | 23.2K | |
| Q1 2021 | 153K | $0.0 $0 | 8 | 8 | 80.4K | $28.07 $2.26 Million | 10 | 5 | 72.1K | |
| Q4 2020 | 841 | $21.36 $17,963 | 2 | 2 | 168K | $26.49 $4.44 Million | 6 | 4 | (167K) | |
| Q3 2020 | 679K | $0.0 $0 | 7 | 5 | 200K | $25.31 $5.05 Million | 6 | 6 | 480K | |